Suppr超能文献

评估结直肠癌的淋巴结比率:并非一刀切。

An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all.

机构信息

Department of General and Colorectal Surgery, University Hospital Limerick, Limerick, Ireland.

出版信息

Int J Colorectal Dis. 2013 Oct;28(10):1377-84. doi: 10.1007/s00384-013-1707-8. Epub 2013 May 29.

Abstract

BACKGROUND

Lymph node ratio (LNR) is increasingly accepted as a useful prognostic indicator in colorectal cancer. However, variations in methodology, statistical stringency and cohort composition has led to inconsistency in respect of the optimally prognostic LNR.

OBJECTIVE

The aim was to apply a robust regression-based analysis to generate and appraise LNRs optimally prognostic for colon and rectal cancer, both separately and in combination.

METHODS

LNR was established for all patients undergoing either a colonic (n = 379) or rectal (n = 160) cancer resection with curative intent. The optimal LNR associated with disease-free and overall survival were established using a classification and regression tree technique. This process was repeated separately for patients who underwent either colonic or rectal resection and for the combined cohort. Survival associated with differing LNR was estimated using the Kaplan-Meier method and compared using a log-rank test. Relationships between LNR, disease-free survival (DFS) and overall survival (OS) were further characterised using Cox regression analysis. All statistical analyses were conducted in the R programming environment, with statistical significance was taken at a level of p < 0.05.

RESULTS

Optimal LNRs differed between each cohort, when either overall or disease-free survival was considered. LNRs generated from combined cohorts also differed from those generated by individual cohorts. In relation to DFS, LNR values were obtained and included 0.18 for the colon cancer cohort and 0.19 for the rectal and combined colorectal cancer cohorts. In relation to OS, multiple LNR values were obtained for colon and combined cohorts; however, an optimal LNR was not evident in the rectal cancer cohort. Survival patterns according to LNR closely resembled those associated with standard nodal staging.

CONCLUSION

Application of a data-driven approach based on recursive partitioning generates differing lymph node ratios for colon, rectal and combined colorectal cohorts. In each cohort, LNR was similarly prognostic to standard nodal staging in respect to overall and disease-free survival. Overall survival was associated with a multiplicity of LNR values, whilst disease-free survival was associated with a single LNR only. The paper demonstrates the merits of utilising a data-driven approach to determining lymph node ratios from specific patient cohorts. Utilising such an approach enabled the generation of those LNRs that were most associated with particular survival trends in relation to overall and disease-free survival. These differed markedly for colon cancer, rectal cancer and combined cohorts. In general, the survival patterns associated with LNRs generated were similar to those observed with standard nodal staging.

摘要

背景

淋巴结比率(LNR)作为结直肠癌的一种有用的预后指标,越来越受到认可。然而,由于方法学、统计学严谨性和队列构成的差异,与最佳预后相关的 LNR 并不一致。

目的

旨在应用稳健的回归分析生成并评估结直肠肿瘤单独和联合切除的最佳 LNR。

方法

对所有接受结直肠(n=379)或直肠(n=160)癌根治性切除术的患者建立 LNR。采用分类回归树技术确定与无病生存和总生存相关的最佳 LNR。分别对接受结直肠或直肠切除术的患者和联合队列重复此过程。使用 Kaplan-Meier 法估计不同 LNR 相关的生存情况,并使用对数秩检验进行比较。使用 Cox 回归分析进一步描述 LNR 与无病生存(DFS)和总生存(OS)之间的关系。所有统计分析均在 R 编程语言环境中进行,以 p<0.05 为统计学意义。

结果

当考虑总生存或无病生存时,每个队列的最佳 LNR 不同。当涉及到 DFS 时,从联合队列中得到的 LNR 值包括结肠癌队列中的 0.18 和直肠及联合结直肠癌队列中的 0.19。当涉及 OS 时,结肠和联合队列获得了多个 LNR 值,但在直肠癌队列中没有确定最佳 LNR。根据 LNR 分层的生存模式与标准淋巴结分期密切相关。

结论

基于递归分区的数据分析生成了不同的结直肠、直肠和联合结直肠癌队列的 LNR。在每个队列中,LNR 在总生存和无病生存方面与标准淋巴结分期同样具有预后意义。总生存与多个 LNR 值相关,而无病生存仅与单个 LNR 值相关。该研究证明了在特定患者队列中使用基于数据驱动的方法确定 LNR 的优点。采用这种方法,可以生成与总体和无病生存相关的特定生存趋势最相关的 LNR。这些在结肠癌、直肠癌和联合队列之间差异显著。总的来说,与 LNR 相关的生存模式与标准淋巴结分期观察到的模式相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验